Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin/clavulanic acid versus no treatment after infected tooth extraction, with probiotic assessment for antibiotic adverse effects
2016-001916-39Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of amoxicillin + clavulanic acid in odontogenic infection (OI) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoints: Post-extraction swelling, Post-extraction pain and 9 more. Started Jun 2021; status: completed.
02
Drugs
amoxicillin + clavulanic acid
03
Conditions
odontogenic infection (OI)
Beyond the preview
Go deeper on 2016-001916-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001916-39.